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Abstract
The Fanconi anemia (FA) gene family is a recent addition to the complex network of proteins that respond to and repair
certain types of DNA damage in the human genome. Since little is known about the regulation of this novel group of genes
at the DNA level, we characterized the promoters of the eight genes (FANCA, B, C, E, F, G, L and M) that compose the FA core
complex. The promoters of these genes show the characteristic attributes of housekeeping genes, such as a high GC
content and CpG islands, a lack of TATA boxes and a low conservation. The promoters functioned in a monodirectional way
and were, in their most active regions, comparable in strength to the SV40 promoter in our reporter plasmids. They were
also marked by a distinctive transcriptional start site (TSS). In the 59 region of each promoter, we identified a region that was
able to negatively regulate the promoter activity in HeLa and HEK 293 cells in isolation. The central and 39 regions of the
promoter sequences harbor binding sites for several common and rare transcription factors, including STAT, SMAD, E2F, AP1
and YY1, which indicates that there may be cross-connections to several established regulatory pathways. Electrophoretic
mobility shift assays and siRNA experiments confirmed the shared regulatory responses between the prominent members
of the TGF-b and JAK/STAT pathways and members of the FA core complex. Although the promoters are not well
conserved, they share region and sequence specific regulatory motifs and transcription factor binding sites (TBFs), and we
identified a bi-partite nature to these promoters. These results support a hypothesis based on the co-evolution of the FA
core complex genes that was expanded to include their promoters.
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Introduction
The Fanconi anemia (FA; MIM #227650) family of genes is an
important component of a multi-member DNA damage defense
network that protects the human genome from the detrimental
consequences of interstrand DNA crosslinks and stalled replication
forks [1]. Fifteen complementation groups and the corresponding
genes have been identified to date [2,3]. To drive the FA/BRCA
pathway,eightoftheFAproteins,FANCA,-B,-C,-E,-F,-G,-Land
-M (NM_000135, NM_001018113, NM_000136, NM_021922,
NM_022725, NM_004629, NM_018062, and NM_020937, re-
spectively), and other facultative components, such as FAAP100,
FAAP24, MHF1 and MHF2, assemble into a nuclear complex
[4,5,6,7,8,9]. Possessing E3 ligase activity, the FA core complex
monoubiquitinates and activates the downstream FA ID complex,
which consists of FANCD2 and FANCI [10]. Some data have
suggested an equimolar ratio of the core complex molecules
[8,11,12],but apartfromthephosphorylation of certain components
in response to DNA damage (via ATR/Chk1 kinases), little is known
about the regulation of the individual genes and the products that
make up the core complex. With the exception of a single report
describing the 59-UTR of FANCC, the putative promoter regions of
the FA core complex genes have not been characterized [13]. The
genes encoding the core complex proteins are located on different
chromosomes, and the resulting proteins vary greatly in size [10]. By
employing in silico methods, we identified the putative promoter
regions as 59 sequence intervals with low degrees of conservation
among vertebrates. Using a standard dual luciferase assay, we were
able to assign the strongest level of activity (corresponding to the
SV40 promoter) to the middle portion of our promoter constructs.
We then looked for the presence or absence of key regulatory motifs
and characterized the distribution and conservation of transcription
factor binding sites throughout the respective promoter regions
[14,15]. Using electrophoretic mobility shift assays (EMSAs), we
investigated the binding affinity of two prominent families of
transcription factors (STAT and SMAD) to the FA promoter
sequences. Because TGF-b signaling may be defective in FA, we
investigated the role of SMAD4 (known as the ‘‘common SMAD’’)
within the context of FA core complex gene regulation. In addition,
SMAD1, STAT1 and STAT4 were studied in gene knockdown
experiments to determine the potential regulatory correlations
between these factors and the promoters of the FA core complex
genes.
Results
Determination of the transcriptional start sites in FA core
complex genes
The TSS information was derived from the database of
transcriptional start sites (DBTSS), where experimentally con-
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e22911firmed TSSs are annotated [16]. The FA core complex genes
proved to be uniformly characterized by a single major TSS,
surrounded by weaker TSSs. This resulted in a relatively broad
distribution and a single dominant peak (PB) [17]. The TSSs were
generally represented by an adenosine. For genes with multiple
putative start sites, we selected the TSS that was most frequently
used in vivo.
Identification of the putative FA core complex gene
promoters
The sequence information from the FA core complex genes and
their flanking sequences were used as guides for the primer design,
and several fragments were cloned from human genomic DNA.
The identities of the genomic DNA fragments were determined by
sequencing. We used three sets of constructs (L1, L2 and L3) that
were designated according to their different lengths. The first
construct (L1) contained the longest sequence, which was
approximately 1 kb upstream of the TSS, and this is a typical
length for several promoters that have been described in the
literature [18]. The second region (L2) was 402–569 bp in length,
and it extended from the most proximal part of the putative
promoter to the middle region. The shortest portion (L3) covered
the region 186 to 250 bp immediately upstream of the TSS
(Table 1).
The activities of the fragments were examined in a transient
transfection experiment using firefly and renilla luciferase con-
structs in HeLa and HEK 293 cells. All of the 59-flanking regions
of the FA core complex genes had significant promoter activities in
the transiently transfected HeLa and HEK293 cells (Fig. 1, A–C).
The FA core complex gene promoters show
characteristics of housekeeping gene promoters
The GC content of the promoters was about 70% and higher
than the average values for the whole genome. A high number of
CpG islands, low conservation through different species and the
lack of TATA boxes are characteristics of housekeeping gene
promoters [19].
Differential activities within the FA core complex gene
promoters
The L1 to L3 series of reporter plasmids contained different
lengths of the FA core complex 59-flanking region (ranging from
1099 bp to 186 bp) and were upstream of the firefly luciferase
gene. To determine the region in these promoters that was
required for maximal activity, they were transiently transfected
into HeLa and HEK 293 cells. To validate our results, we
compared the luciferase activities obtained with the FA gene
promoters to those obtained with two known promoter sequences.
We tested the SV40 promoter as a strong promoter that was
inserted into the pGL SV40 plasmid, and we used the minimal
promoter of the human GLI3 gene (NM_000168; Greig
cephalopolysyndactyly syndrome; MIM #175700) as an example
of a relatively weak promoter [20].
The L1 region accounted for 20% to 50% of the activity of the
SV40 promoter (Fig. 1A). A high activity was consistently observed
with the L2 region (40% to 115%; Fig. 1B); however, the mean
value of the L3 region showed even greater activity (50% to 203%;
Fig. 1C). Nevertheless, occasionally some L2 regions show a higher
activity than their L3 equivalent (FANCA, -L and -M). The
activities of both L2 and L3 were comparable to the SV40
promoter activity. These results showed that the strongest activities
of the FA core complex gene promoters were exerted by those
neighboring the TSS and that promoter activity decreased as the
distance upstream of the TSS increased.
In terms of single FA genes, the FANCA- and FANCM-derived
L2 constructs showed 20% higher activity than the SV40
promoter (Fig. 1B). In contrast, the L2 FANCF promoter
construct, which showed the weakest promoter activity of all of
the core complex genes, displayed twice the activity of the GLI3
promoter and half of the activity of the SV40 promoter. The L3
portion of the FANCF promoter showed the highest activity, which
was twice the activity of the SV40 promoter (Fig. 1C).
A feature that was common to all the cloned promoter
fragments was their monodirectional activity. This was determined
by cloning the L2 promoter fragments in reverse complementary
orientation into the pGL3 basic plasmid. With the exception of the
FANCB promoter, all the other constructs showed little or no
activity in the dual luciferase assay in the reverse orientation
(Fig. 2A).
Antagonistic FA promoter activity
To further characterize the activity within the 59 portions of the
FA core complex gene promoters, we amplified the regions from
the 59 end of L1 to the 59 end of L2. One was amplified in the
sense direction and one in the reverse-complement orientation,
and the products were cloned into the pGL3 SV40 vector (Figs. 2B
and C). As a control, we cloned a sequence extending exactly
Table 1. Promoter data of the FA core complex genes.
Promoter region size Region relative to the TSS
gene chromosome start end strand L1 L2 L3 L1 L2 L3
hg 19
FANCA 16 89883006 89884049 (2) 1044 bp 425 bp 219 bp 21002/+42 2383/+42 2177/+42
FANCB X 14891150 14892204 (2) 1055 bp 436 bp 250 bp 21021/+34 2402/+34 2216/+34
FANCC 9 98079252 98080351 (2) 1099 bp 402 bp 186 bp 21098/+1 2401/+1 2185/+1
FANCE 6 35419104 35420181 (+) 1078 bp 410 bp 225 bp 21034/+44 2366/+44 2181/+44
FANCF 11 22647334 22648403 (2) 1069 bp 415 bp 232 bp 21046/+23 2392/+23 2209/+23
FANGG 9 35079995 35081083 (2) 1089 bp 569 bp 193 bp 21071/+18 2551/+18 2178/+18
FANCL 2 58468480 58469550 (2) 1071 bp 466 bp 223 bp 21065/+6 2460/+6 2217/+6
FANCM 14 45604137 45605214 (+) 1077 bp 456 bp 234 bp 21012/+65 2391/+65 2169/+65
doi:10.1371/journal.pone.0022911.t001
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to rule out any site-specific, random repression-like effects due to
insertions upstream of the SV40 promoter. The inserts that were
cloned in a strand-specific manner differed greatly and this
suggests a direction-specific inhibition. The constructs from the
FANCA, FANCC and FANCE promoters reduced the firefly
luciferase activity to less than 40% of the expression level of the
SV40 promoter alone (Fig. 2B). The constructs of the FANCB,
FANCF, FANCL and FANCM promoters showed even lower
activities (5% to 30%) compared to the SV40 promoter alone,
which was consistent with the idea that all of these sequences may
provide negative activity. The effect of the reverse complement
inserted sequences was marginal in both HeLa and HEK293 cells,
with a luciferase activity comparable to the control (74% to 98% of
the original activity). Our results suggest that the regions upstream
of the 59 end of the L2 sequences act as strand specific silencing
Figure 1. A schematic representation of different FA gene promoter constructs in pGL3 and their measured activities. (A) The longest
insert (L1) covers the entire promoter region (,1 kb) upstream of the TSS. (B) L2 is a smaller insert of ,500 bp. (C) L3 is the smallest insert and is
,220 bp upstream of the TSS. In all the samples, the positive control (pGL3 SV40) was set as 100%. The GLI3 promoter served as the reference for a
weak promoter. The results for the HeLa cells are in dark gray, and the results for the HEK 293 cells are in light gray.
doi:10.1371/journal.pone.0022911.g001
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experiments we did not observe a significant or systematic
difference in the results between the HeLa and HEK293 cell
lines in their normal or reverse orientations.
The FAAP100 promoter
FAAP100 (NM_025161) is a recently described member of the
core complex and the FANCB-FANCL-FAAP100 subcomplex
[5]. FAAP100 is not yet designated as an authentic FA protein
because patients with mutations in this gene have not been
identified to date. Therefore, FAAP100 was not included in all
of our analyses. However, to characterize the FAAP100
promoter and determine similarities, we divided the putative
promoter region (approximately 1 kb) into five segments with
lengths of approximately 200 bp. We then cloned the corre-
sponding PCR products into the pGL3 basic plasmid. We
measured each of these fragments using the dual luciferase assay
in comparison to FANCA in the HEK293 line. We did not detect
any significant activity in the 59 region of the promoter sequence
of FAAP100 within 21000 to 2601 nt of the TSS, which was
divided into 200 bp fragments (Fig. 2D). The section from 2600
to 2401 nt showed weak promoter activity of no more than
15% of the SV40 promoter activity. The highest level of activity
(approaching 95% of the SV40 promoter) was observed in the
region from 2400 to 2201 nt. The final segment (2200 to
+1 nt) showed intermediate activity, which was 45% of the SV40
promoter activity. These results indicate that the FAAP100
promoter has an activity pattern similar to the patterns observed
for the other core complex genes, as shown in detail for the
FANCA promoter.
Figure 2. Results of the dual luciferase assays for additional constructs. (A) Results for the reverse complementary region (L2). The activity
was strongly reduced in both cell lines. (B) The region extending from the 59 end of the entire promoter region to the 59 end of the L2 region was
cloned into the pGL3 SV40 vector. It displayed low promoter activity. (C) The same region in (B) but cloned in a reverse complementary orientation.
(D) The differential activity in FAAP100, compared to the FANCA promoter. The results for FAAP100 are in white, and the results for FANCA are in black.
The experiment was performed in HEK293 cells.
doi:10.1371/journal.pone.0022911.g002
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With the help of the Multiple Em for Motif Elicitation (MEME)
software, we identified several DNA sequence motifs that were
present in nearly all of the promoter regions of the FA core
complex genes. These motifs consisted of short sequences that are
distributed throughout the entire tested region (Fig. 3A and B).
However, in the 59 region of the promoter sequences, these
common motifs failed to follow a specific pattern. The 59 region
(approximately 21000 to 2550) was found to harbor a more
random distribution of the DNA motifs that did not contain
transcription factor binding sites. In contrast, there were two
specific pattern-forming sequence motifs that were clustered in the
central portion of the promoter regions (positions 2250 to 2550).
Fig. 3C depicts these motifs as sequence logos and shows the
transcription factor binding sites within these sequence motifs. The
sequence motif that is indicated by a purple bar includes one
binding site each for E2F and TFII-I. The sequence represented
by the green bar contains one binding site for E2F. There seemed
to be no correlation between the numbers and types of the two
DNA motifs and the promoter strength.
Predicted transcription factor binding sites (TBSs)
Using in silico approaches (PROMO and the Genomatix suite),
we identified a large number and variety of TBSs. Therefore, we
Figure 3. The distribution of conserved DNA motif blocks within the FA core complex gene promoters. (A) The 59- region with a
seemingly random distribution of three different sequence motifs. Each motif occurred no more than once per gene. (B) Within the region extending
from 2250 to 2550, two sequence motifs (purple and green bars) are present repeatedly or combined in most of the tested FA genes. (C) The DNA
sequences of the two motifs. The degree of nucleotide conservation is indicated by the height of the respective letters. The purple color represents
the upper sequence, and the green color represents the lower sequence.
doi:10.1371/journal.pone.0022911.g003
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similarities: 70% and 85%. However, the overall set of TBSs was
similar in all of the L1 promoter fragments. Some binding sites
were shared by all of the FA core complex gene promoters,
including those for the TFII-I, TFIID, E2F, STAT4, YY1, c-Jun
and IRF1 proteins, and an additional group of shared, but not
ubiquitously present, binding sites were found (Table 2). The
important cis-regulatory elements were not distributed over the
entire promoter region, but they were clustered within the portions
with the highest transcriptional activity, including most of the E2F,
YY1, STAT1, SMAD, AP1 and SP1/GC box cis-regulatory
elements. The SMAD sites were not represented as often as the
STAT or other sites in the 85% matrix similarity interval.
However, we also focused on the SMAD sites, because of the data
in the literature for FANCA [21] and crosstalk between STAT and
SMAD [22]. The general importance of these TBSs was illustrated
by a patient-derived FANCL genomic deletion that removes
219 bp of sequence upstream of the TSS and led to the loss of a
region with a large number of TF recognition sites. This deletion
resulted in a remarkable breakdown of transcription in vitro (Fig. 4).
Confirmation of DNA-protein interactions
EMSA techniques were used to examine the DNA-protein
interactions between the FA core complex promoters and the
transcription factors that were predicted by the in silico tools. We
focused on STAT1/4 and SMAD1/4 as the prominent members
of known regulation-associated pathways [23,24]. In each of the
tested promoter sequences, we found either a STAT or a SMAD
binding site. A prominent band shift was observed when the HeLa
cell extract was incubated with the biotin-labeled oligonucleotide
(Figure 5, lane 2). To prove the specificity of the observed
interaction, we added a 200-fold molar excess of unlabeled,
specific competitor sequences and the band shift was suppressed
(Fig. 5, lane 3). Due to the binding of the specific, unlabeled
competitor this band proved the specificity of the interaction in all
experiments.
The expression of FA core complex genes is influenced
by STAT1/4 and SMAD1/4
The results of our siRNA experiments support the notion of
shared regulatory functions between the FA core complex gene
promoters and prominent cellular pathways, such as TGF-b and
JAK/STAT. Following siRNA knockdown of STAT1/4 or
SMAD1/4, we examined the mRNA expression of the FANC
core complex genes. Knockdown of STAT1 led to a significant
decrease in the amount of detectable FANCA, -B, -C, -E and -L
transcripts. Less than 15% of the normal level of transcript was
present for these genes, which contain STAT1-responsive
promoters (Fig. 6A). A similar, but slightly more variable outcome
was obtained after SMAD1 knockdown. The amount of signifi-
cantly reduced FA gene transcripts (FANCB, G, -L and -M) varied
from 27% to 3% of their original expression (Fig. 6B). These
results indicate that two prominent members of the TGF-b and
JAK/STAT pathways assume regulatory functions within the FA
core complex gene promoters. A similar regulatory effect of
STAT4, which is another member of the JAK/STAT pathway,
was also observed (Fig. 6C). The siRNA induced downregulation
of STAT4 caused significant decreases in FANCA,- E and -F
transcripts. The maximum transcript level for FANCA was 27% of
the non-treated samples (p,0.05). The results of the SMAD4
knockdown studies in the HeLa cells are of special note because a
direct regulatory interaction between SMAD4 and FANCA has
been previously reported in mice [21].
Following SMAD4 downregulation, FANCA showed the stron-
gest decrease in expression, which was 10% (0.1-fold) of the
original transcript level (Fig. 6D). FANCC, -F and -L were also
downregulated, although less dramatically and with more
variability (22%–37%). Control western blots showed an adequate
knockdown of the transcription factors (Fig. 6E).
To exclude cell specific effects, we repeated our knockdown
experiments in a wild-type, primary human fibroblast cell strain
(MCNA; con) and compared these results to patient-derived
cultured fibroblasts carrying biallelic mutations in FANCA (MAKE;
FA-A). Inactivating SMAD4, STAT1 and STAT4 caused FANCA
downregulation in both the wild-type and the mutated cells
(Fig. 7A). There was no response for SMAD1, and both of these
findings were consistent with our previous experiments in HeLa
cells. The western blots demonstrated an adequate knockdown of
the transcription of these genes (Fig. 7B). Almost no visible
FANCA protein was observed due to the SMAD4/STAT1
knockdown (Fig. 7C, lane 2). Protein derived from a patient who
belongs to the Fanconi anemia complementation group A (FA-A)
is shown in lane 3 (Fig. 7C).
Discussion
The aim of our study was to determine the structural and
functional features of the regulatory machinery that drives the FA
core complex genes. This included the common and rare
transcription factor binding sites and their distribution. Similarities
Table 2. Transcription factor binding sites not common to all of the FA core complex genes.
FANCA FANCB FANCC FANCE FANCF FANCG FANCL FANCM
STAT1beta STAT1beta STAT1beta STAT1beta STAT1beta STAT1beta STAT1beta STAT1beta
SP1 SP1 SP1 SP1 SP1 SP1
XCPE XCPE XCPE XCPE XCPE XCPE
AP1 AP1 AP1 AP1
SMAD SMAD
1 SMAD
1 SMAD SMAD
1
GATA3
1 GATA3
1
STAT5A STAT5A STAT5A STAT5A STAT5A
c-Fos c-Fos
NFkB
1 NFkB
1
1This factors were found only with a 70% sequence similarity.
doi:10.1371/journal.pone.0022911.t002
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of FA core complex genes.
The cloned FA core complex gene promoter regions have
characteristics that are typical of housekeeping genes. These
characteristics include the following: a high GC content and CpG
islands, a lack of obvious TATA or CCAAT regulatory sequences,
and the presence of several transcription factor binding sites,
including YY1, STAT1, AP2 and SP1/GC box cis-elements [19].
These properties suggest that the FA core complex gene promoters
belong to a distinct subgroup of genes that are characterized by a
dominant TSS surrounded by several weaker TSSs [17]. Our data
showed that the region with the highest activity was situated within
the central and proximal sections of the promoters, which is
typically a high-activity region that has been described for a
number of other genes [25,26,27]. Compared to the SV40
promoter, our L2 and L3 constructs showed comparable and
sometimes higher activities, indicating that these regions harbor
strong elements for the direction of the preinitiation complex. This
was unexpected because the FA family of genes and their proteins
are members of developmental and genome maintenance
pathways that are similar to the GLI3 promoter and show mostly
weak activity [20]. The lower level of activity that was observed
with our L1 construct suggests the presence of a silencing element
(or repressor) within this particular region. This is not without
precedent because silencing elements have been identified in the
human AZFa gene promoter [28], even if they are in a
monodirectional position. The FA core complex genes are
distributed independently and widely throughout the genome.
With the exception of FANCB, these genes generally do not
overlap with other genes on a large scale. In the present study,
FANCB was the only gene with a slight bidirectional, basal
promoter activity in the dual luciferase assay (Fig. 2A). This might
be because FANCB harbors a promoter region that partially
overlaps the human MOSPD2 (motile sperm domain containing 2)
gene. Cell-specific effects on the measurements were excluded
because the results differed marginally between the cell lines.
The transcriptional regulation of genes that participate in
protein complex formation is often marked by sequence
similarities [29,30]. Two different motifs were characterized
within the most active part of the promoters that were specific
to the FA core complex gene in this particular combination
(Figs. 3B and C). With the exception of FANCF, all of the core
complex gene promoters feature one or both of these two motifs,
albeit in different numbers. Similar to what has been reported for
FANCD2, the presence of binding sites for E2F in these motifs
suggests that the E2F/Rb pathway also may be involved in
regulating the FA core complex [31]. Furthermore the location of
these motives in the 39 region in combination with the silencing
elements in the 59 region underlined the bi-partite nature of these
promoters.
Regulation of the JAK/STAT pathway by the FA/BRCA
pathway has been noted previously [32]; however, in this study, we
asked the opposite question, regulation of FA/BRCA by the JAK/
STAT pathway. Our in silico data indicated that all of the FA core
complex gene promoters featured one or more of the STAT1/4/5
Figure 4. The promoter mutation in FANCL. The 219 bp deletion in
the proximal region of the promoter led to a strong reduction in
promoter activity.
doi:10.1371/journal.pone.0022911.g004
Figure 5. Electrophoretic mobility shift assay (EMSA) illustrat-
ing the DNA/protein interactions between the FA gene
promoters and STAT/SMAD. (A) A positive result (band shift) was
observed with all the tested FA genes. Lane 1: control, Epstein-Barr
nuclear antigen (EBNA) extract. Lane 2: affirmed interactions. Lane 3:
200-fold molar excess of unlabeled DNA (cold competitor) as the
control for specificity. (B) In these control reactions an additional non
specific, but labeled oligo (E.coli M13) was added to show that a
positive shift was not caused by the addition of any type of DNA
(unspecific shift).
doi:10.1371/journal.pone.0022911.g005
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STAT1. Independent but closely spaced DNA binding sites for
STAT and other transcription factors seem to be required for
maximal transcriptional activity [33]. In contrast to the uniform
presence of STAT binding sites, a SMAD binding site was
detected only in the FANCG and FANCA promoters and, with a
lower consensus conservation, in FANCB, FANCF and FANCL.
This suggests that SMAD participates in a regulatory network that
includes TGF-b [23,34,35]. To include SMAD in our analyses, we
were encouraged by other studies that suggested that STAT and
SMAD may form a complex and work cooperatively [36,37]. A
further demonstration of SMAD driven regulation is the AP1 and
c-Jun/c-Fos binding sites that are present in most of the core
complex FA gene promoters. The SMAD consensus motif,
GTCTAGAC, is a palindromic sequence with two copies of
GTCT, with its reverse compliment AGAC on the opposite
strand. Tandem repeats of this sequence have been shown to
promote TGF-b-inducible transcriptional activation [38]. SMAD
also binds to TGAGTCAGAC, an AP1 binding site (TGAGTCA)
that overlaps with an AGAC-containing SMAD-binding sequence
[39]. A direct influence of SMAD4 on FA gene expression has
been previously shown in mice [21] and was confirmed by the
present study. Of note, loss of SMAD4 increases genomic
instability and appears to contribute to the emergence of head
and neck squamous cell carcinoma (HNSCC), which is a tumor
that is frequently encountered in FA patients [21,40].
There are only single reports concerning the possible cross-talk
between two of the FANC core complex genes (FANCA and
FANCC) and the TGF-b and JAK/STAT pathways [32,41,42].
Our present study confirms and extends these findings to all of the
FA core complex members. To substantiate the results that were
obtained with the HeLa cells, we repeated and confirmed the
results of our experiments using normal (control) or FA-A primary
fibroblast cultures.
The regulation of the FA core complex genes is unlikely to occur
only through their promoters at the genomic level. Regulation at
the transcript level has been recognized as an important aspect in
the control of expression for many genes. In Drosophila, the box
motifs ‘‘(the K box, the GY box and the Brd box)’’ appear to
function as regulatory elements for the Notch signaling pathway
[43,44]. As mediators of miRNA binding, these three sequence
motifs play key roles in regulating gene expression [43,44,45,46].
Our analysis showed that K-boxes occur in most of the FA core
complex transcripts, and at least one of these motifs can be
predicted in each transcript, with the exception of FANCE.
Collectively, our study provides the first approximation of the
features that govern the activity of the FA core complex group of
genes. Based on the similarities, our analysis also adds support to
the hypothesis of co-evolved promoters within this group. Given
the importance of DNA damage recognition and repair for the
prevention of premature cancer and aging, it seems reasonable for
evolution to have provided additional protection for long-living,
warm-blooded species. These protections include a certain degree
of regulatory and functional redundancy, which was found in the
FA core complex genes.
Materials and Methods
The used fibroblast cell line MAKE derived from a Fanconi
anemia patient, which is unknown to me, during the routine
diagnostic process. The cell line was neither used for clinical studies
nor for other studies and was processed anonymously. It is used only
Figure 6. The consequences of STAT and SMAD downregulation on FA gene expression in HeLa cells. (A) The strongly reduced mRNA
expression of FANCA, -B, -C, -E and -L following STAT1 knockdown in the respective FANC gene (FANCA, -B, -C, -E, -F, -G, -L and M correspond to lanes
1–8, respectively). (B) The SMAD1 knockdown results in decreased levels of FANCB,- G, -L and -M mRNAs. (C) The mRNA levels of FANCA, -E and -F were
reduced following the siRNA treatment directed against STAT4.( D) Following the SMAD4 inactivation, FANCA, -C, -F and -L exhibited reduced mRNA
levels. (E) A western blot showing the effective transcription factor knockdown. The first three columns denote the controls as follows: (2)
untransfected HeLa cells, (+) knockdown using siRNA directed against the gene of interest, and (NT) transfection with a non-targeting siRNA. All the
results were derived from triplicate assays. *p,0.05.
doi:10.1371/journal.pone.0022911.g006
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German gene diagnostic law that require the consent of the patient
and/or their parents. For this type of use of patient material no
approval of anethicscommittee isrequired in German law. Awritten
informed consent was obtained for research on this patient sample.
PCR
Three products were amplified that were 59 to the putative
transcription start site (TSS; labeled L1, L2 and L3) for each of the
core complex genes. L1, L2, and L3 were approximately 1 kb,
500 bp, and 200 bp upstream of the TSS, respectively. Primer
sequences were generated using the Primer3 program (www.frodo.
wi.mit.edu). Phusion DNA Polymerase (Finzymes) was used
primarily, but the CG-rich PCR kit (Roche) was used for difficult
templates, such as those with CG-rich regions. All the PCR
experiments were performed in a volume of 50 ml and a primer
concentration of 10 pmol. With the exception of the FAAP100
primers, all the primers were generated with a KpnI restriction site
at the forward strand and a HindIII site at the reverse strand. For
FAAP100, we used a MluI site on the forward strand because there
was an internal KpnI site in the sequence. The GLI3 promoter is a
reference promoter with relatively weak activity, and it was
amplified with KpnI/HindIII restriction sites.
Generation of plasmid constructs
The amplified PCR products were digested with their respective
enzymes and ligated into the pGL3-Basic Vector (Promega), which
contains the gene for firefly luciferase. To test the putative
silencing properties of the 59 FA promoter regions, we used the
pGL3 SV40 vector. The constructs were transformed into
competent Escherichia coli TOP10 (Invitrogen) or Turbo (NEB)
cells according to the manufacturer’s instructions. The integrity
and direction of all the inserts were confirmed by sequence
analyses using the RVprimer3 (forward) and the GLprimer2
(reverse) sequencing primers (Promega), which bind directly up-
and downstream of the multiple cloning sites. Primer sequences
are available upon request.
Cell culture, transfection and dual luciferase assay
HeLa and HEK 293 cells (DSMZ-German Collection of
Microorganisms and Cell Cultures) were grown in MEM
containing 10% FCS (Gibco) and 1% penicillin/streptomycin
(Gibco) under standard cell culture conditions (37uC and 5%
CO2/95% air). The transfections were performed with Effectene
transfection reagent (Qiagen) according to the manufacturer’s
protocol. Briefly, 24 h before transfection, cells were split into 12-
well plates (200,000 cells/well) at a confluence level between 50
Figure 7. FANCA mRNA expression in normal control (MCNA) and FA-A (FA-A) primary human fibroblasts after siRNA treatment
against SMAD1, SMAD4, STAT1 and STAT4. (A) Wild-type and FA-A controls (MCNA; FA-A) were left untreated. MCNA was also transfected with
non-target siRNA. FANCA siRNA transfected con cells and patient-derived FA-A cells served as the positive controls. The results using primary
fibroblast cell strains confirmed the results obtained in the HeLa cell system. (B) A western blot showing the effective transcription factor knockdown.
(C) Depletion of FANCA protein was detected by an anti-FANCA antibody to determine the effectiveness of the knockdown at the protein level.
Control untreated (lanes 1). SMAD4 and STAT1 siRNA-treated cells showed marginally detectable FANCA protein (lanes 2). FANCA-mutated (FA-A)
cells are shown for comparison (lanes 3). The nuclear matrix protein (p84) served as a loading control.
doi:10.1371/journal.pone.0022911.g007
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basic vector (firefly) with our inserts, the pRL null vector (renilla)a s
an internal control, and 87 ml of transfection reagent (75 mlo fE C
Buffer, 6 ml of Enhancer and Effectene). At 48 h after transfection,
the cells were washed with PBS and lysed with passive lysis buffer
(Promega) to perform a conventional dual luciferase assay (DLR).
Lysate (20 ml) was placed into each well of a white 96-well plate
and measured with a Mithras Luminometer (Berthold Technol-
ogies). The DLR was performed according to the manufacturer’s
instructions, except that the amount of substrate was reduced to
50 ml per aliquot.
Preparation of nuclear extracts
HeLa cells were used for the extraction of nuclear proteins using
the NE-PER nuclear and cytoplasmic extraction reagents [47].
The cells were harvested with trypsin-EDTA and then centrifuged
at 5006 g for 5 minutes. The extraction steps were performed
according to manufacturer’s instructions. Nuclear extracts were
stored at 280uC until use.
Electrophoretic mobility shift assay (EMSA)
We performed a non radioactive, biotin labeled chemiluminescent
EMSA [47]. We used oligonucleotides for the following binding
reactions: FANCA/STAT, FANCB/STAT, FANCB/SMAD, FANCC/
STAT, FANCE/STAT, FANCF/STAT, FANCG/STAT, FANCL/
STAT, FANCM/STAT, and FANCM/SMAD. Binding reactions
were performed for 20 min at room temperature in the presence of
poly(dI-dC) (50 ng/ml), 0.05% Nonidet P-40, 5 mm MgCl2,1 0m m
EDTA, and 2.5% glycerol in 16 binding buffer (LightShift
chemiluminescent EMSA kit, Pierce) and biotin-end-labeled target
DNA (20 fmol) and nuclear extract (4 mg). Unlabeled target DNA
(4 pmol) was added per 20 ml of binding reaction where indicated.
After a pre-electrophoretic run for 30 min at 100 V in 0.56 Tris
borate/EDTA, aliquots were loaded onto 6% DNA retardation gels
(Invitrogen) and electrophoresed for 50 min at 100 V. The gels were
then transferred onto a positively charged nylon membrane (Nytran
SPC, Whatman) in 0.56Tris borate/EDTA at 380 mA for 50 min.
The samples were cross-linked to the membrane for 15 min on a
transilluminator equipped with 312 nm bulbs. Detection was
performed using horseradish peroxidase-conjugated streptavidin in
combination with the chemiluminescent substrate (LightShift chemi-
luminescent EMSA kit) according to the manufacturer’s instructions.
siRNA experiments
Knockdown experiments were performed in HeLa cells, non-
FA human fibroblasts (ATCC; American Type Culture Collection)
and in a patient derived, primary fibroblast cell lines that were
either FANCA wild-type (MCNA; con) or which had compound,
heterozygous FANCA mutations (MAKE; c.3349-1 G.A and
c.4069 G.C; written and informed consent was obtained for this
patient sample. For this type of use of patient material no approval
of an ethics committee is required in German law). We used ON-
TARGETplus siRNA (Dharmacon) against STAT1, SMAD1,
STAT4 and SMAD4 and a DharmaFECT transfection reagent.
Twenty-four h before transfection, the cells were split into 12-well
plates (150,000 cells/well for HeLa cells and 120,000 cells/well for
fibroblasts) at a confluence level between 50% and 80%. The
transfections used siRNA solutions (5 mM) in 16 siRNA buffer
(Dharmacon). The transfection reactions were performed accord-
ing to the manufacturer’s instructions. After 48 h, the cells were
harvested for mRNA analyses.
RNA extraction, cDNA synthesis and qRT-PCR analyses
Total RNA was obtained with the RNeasy Kit (Qiagen), and it
was used for DNase digestion and cDNA synthesis. Up to 10 mgo f
RNA was treated with the TURBO DNA-free kit (Ambion) at
37uC for 30 min to remove contaminating DNA. Total RNA
(1 mg), anchored oligo(dT)18 primer (2.5 mM) and reverse
transcriptase (10 U) from the transcriptor high fidelity cDNA
synthesis kit (Roche) were used for the first strand synthesis
according to the manufacturer’s suggestions. The cDNA was
stored at 220uC.
The qRT-PCR primers for STAT1, STAT4, SMAD1, SMAD4
and FANCA were determined using Primer Design
TM. Each of the
samples was examined in triplicate and subjected to qRT-PCR
using PerfeCTa SYBR Green SuperMix (Quanta). GAPDH, ACTB
and UBC probes were used as internal controls. The relative RNA
expression levels were determined by normalizing them to internal
controls, and the values were calculated using the comparative Ct
method. Statistical differences between 2 groups of data were
analyzed using the 2-tailed Student’s t test. P values less than 0.05
were considered significant.
Western blot analysis
After the knockdown experiments were completed, immuno-
blots were performed with the samples containing total protein
(40 mg) and 7% NuPage Tris-acetate polyacrylamide gels (Invitro-
gen). The membranes were probed with rabbit polyclonal anti-
FANCA (1:1000; Abcam ab5063). The secondary antibody was a
horseradish peroxidase-linked donkey anti-rabbit IgG (1:4000; GE
Healthcare NA934V), and it was detected by the chemilumines-
cence technique using the ECL system (Amersham). For a loading
control, we used a mouse monoclonal anti-p84 (nuclear matrix
protein 84; 1:2000; Abcam ab487). The secondary antibody was a
horseradish peroxidase-linked goat anti-mouse IgG (1:5000;
Abcam; ab20043).
Bioinformatics
The promoter regions were predicted in silico using the
promoter prediction and gene2promoter programs (www.
genomatix.de) and the UCSC genome browser. The TSSs were
taken from the DTSS database where the TSS data were
generated by massively sequencing the full-length cDNAs in
humans and mice (www.dbtss.hgc.jp). The putative promoter
sequences were analyzed for transcription factor binding sites
with two software tools: Mat Inspector (Genomatix), and the
PROMO tool/database with two sets of similarity (70% and
85%) (Transfac 8.3) (http://alggen.lsi.upc.es/cgi-in/promo_v3/
promo/promoinit.cgi?dirDB=TF_8.3) [48,49]. The MEME
suite can be found under the following link: http://meme.
sdsc.edu/meme4_5_0/intro.html.
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